Watch now! Oved Amitay talks to Llewellyn King on “ME/CFS Alert”

In the most recent episode of “ME/CFS Alert,” host Llewellyn King interviewed Solve M.E. President and CEO, Oved Amitay. Oved, a registered pharmacist and public health expert who has dedicated his professional career to the development of therapeutic options for people affected by rare genetic diseases, spoke to King about the recent $1.15 billion congressional […]

Read More

Meet Our 2021 Advocacy Week Partners

Advocacy Week Welcomes Partners from Long COVID and Rare Disease Communities The 5th Annual Solve M.E. Advocacy Week will take place from Sunday, April 18, 2021 to Saturday, April 24, 2021. This year, “ME/CFS & Long COVID Advocacy Day” welcomes our new partners from the Long COVID Alliance and the EveryLife Foundation for Rare Diseases […]

Read More

Why Long-COVID?

The Long COVID Alliance is a coalition of different complex, chronic, disease organizations who have come together to pool our resources. Each group is bringing along their expertise as well as their connections with patient advocates, disease experts, drug developers, and more. The top three symptoms of long-COVID are the top three symptoms of ME/CFS, […]

Read More

Solve M.E. Spearheads Formation of Long COVID Alliance to Accelerate Post-Infectious Research

  Today, Solve M.E. warmly welcomes 50 new partners in the fight to return millions of Americans to health. The Long COVID Alliance, launched by Solve M.E., is a network of patient-advocates, scientists, disease and public health experts, and drug developers, who have joined together to leverage our collective knowledge and resources to educate policy […]

Read More

Ramsay Grant Program 2021 RFA is Open!

Solve M.E. will accept applications to study ME/CFS and Long-Covid from February 22 – April 30, 2021 Through the Ramsay Program, Solve M.E. invests in research studies in ME/CFS or long-COVID with a particular emphasis on engaging young investigators and researchers new to the field. Collaborative proposals (involving 2 or more research groups) and studies […]

Read More

NIH launches database to track neurological symptoms associated with COVID-19

A new database will collect information from clinicians about COVID-19-related neurological symptoms, complications, and outcomes as well as COVID-19 effects on pre-existing neurological conditions. The COVID-19 Neuro Databank/Biobank (NeuroCOVID), which was created and will be maintained by NYU Langone Health, New York City, will be a resource of clinical information as well as biospecimens from […]

Read More